Ruxolitinib-induced extreme thrombocytosis in a COVID-19 patient

Detalles Bibliográficos
Autores principales: Anguiano-Álvarez, Víctor Manuel, Maza-Larrea, José Antonio, Rosado-Hernández, Francisco Javier, Rojas-Velasco, Gustavo, Izaguirre-Ávila, Raúl
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis 2021
Materias:
Letters to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8478626/
https://www.ncbi.nlm.nih.gov/pubmed/34400588
http://dx.doi.org/10.5045/br.2021.2020245

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8478626/
https://www.ncbi.nlm.nih.gov/pubmed/34400588
http://dx.doi.org/10.5045/br.2021.2020245

Ejemplares similares